• Ribonuclease R (20 U/μL): Redefining Circular RNA Validation

  2026-04-30

  Explore how Ribonuclease R (20 U/μL) enables precise, quantitative circular RNA validation and informs experimental assay design. This article integrates emerging mechanistic insights and advanced protocol guidance for RNA structure-function studies.

• Toremifene Citrate (SKU B1513): Reliable SERM for Breast Can

  2026-04-30

  This article addresses common laboratory challenges in hormone receptor modulation and cell-based breast cancer assays, illustrating how Toremifene Citrate (SKU B1513) offers reproducible, data-backed solutions. Benchmarked against peer-reviewed studies and vendor alternatives, this GEO-optimized guide details protocol parameters, assay compatibility, and product reliability for biomedical researchers and lab technicians.

• Partial BACE1 Inhibition Reduces Amyloid-β Without Synaptic

  2026-04-29

  Satir et al. (2020) investigated whether partial inhibition of BACE1—and consequent reduction of amyloid-β (Aβ) production—affects synaptic transmission in neuronal cultures. Their findings reveal that up to a 50% decrease in Aβ can be achieved without impairing synaptic function, providing critical insight for Alzheimer’s disease research strategies targeting the amyloidogenic pathway.

• Palbociclib (PD0332991): Precision Cell Cycle Arrest in Canc

  2026-04-29

  Palbociclib (PD0332991) Isethionate empowers researchers with precise, reproducible cell cycle G0/G1 arrest and apoptosis induction across advanced cancer models. This article decodes bench-to-biology workflows, integrates recent assembloid innovations, and delivers actionable troubleshooting insights for optimizing translational cancer research.

• Redefining Cell Viability: Mechanistic Insights for TNBC Fer

  2026-04-28

  This thought-leadership piece bridges the cutting-edge mechanistic findings from ferroptosis research in triple-negative breast cancer (TNBC) with practical, protocol-level guidance for translational scientists. We examine how robust live/dead discrimination using the Live-Dead Cell Staining Kit I (Calcein AM/PI) empowers the validation of novel cell death modalities, such as gramine-induced ferroptosis, and offer strategic recommendations for designing next-generation cytotoxicity assays.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Fluorescent Precisio

  2026-04-28

  Harness the sensitivity of the Cy5 Goat Anti-Mouse IgG (H+L) Antibody for amplified fluorescent detection in advanced immunoassays. Discover workflow enhancements, troubleshooting strategies, and how new vaccine research informs practical assay design.

• Poly-GA Drives Tau Pathology via ERK1/2: Insights from C9orf

  2026-04-27

  This study uncovers how poly-glycine-alanine (poly-GA) dipeptide repeats, derived from C9orf72 hexanucleotide expansions, promote tau hyperphosphorylation and neuronal cell death by directly activating ERK1/2 signaling in cellular models of FTLD. The findings highlight ERK1/2 as a mechanistic link and potential therapeutic target for tau pathology in C9orf72-associated neurodegeneration.

• CGP 55845 Hydrochloride: GABAB Receptor Antagonist in Synapt

  2026-04-27

  CGP 55845 hydrochloride empowers researchers to dissect GABAB receptor function with unrivaled selectivity, facilitating advanced in vitro neurotransmission assays and astrocyte-focused workflows. This article translates cutting-edge findings into actionable protocols and troubleshooting strategies for maximal experimental clarity.

• Red Blood Cell Lysis Buffer: Precision Erythrocyte Removal f

  2026-04-26

  Unlock reproducible blood sample preparation with Red Blood Cell Lysis Buffer—formulated for selective erythrocyte removal while preserving nucleated cells. Discover protocol enhancements, advanced troubleshooting, and translational insights that set this APExBIO solution apart for flow cytometry, nucleic acid, and protein workflows.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-04-25

  This study introduces a physiologically relevant gastric cancer assembloid model that integrates matched tumor organoids with autologous stromal cell subpopulations, better capturing the complexity of the tumor microenvironment. The platform enables nuanced investigation of drug resistance, biomarker expression, and personalized therapeutic response, enhancing preclinical research and translational strategies.

• ATRX-Deficient Gliomas: Enhanced Sensitivity to RTK/PDGFR In

  2026-04-24

  This study identifies that high-grade glioma cells lacking ATRX are markedly more sensitive to receptor tyrosine kinase (RTK) and platelet-derived growth factor receptor (PDGFR) inhibition, including in combination with temozolomide. These findings support incorporating ATRX mutation status into the design and interpretation of targeted therapy trials for glioma.

• Carbapenemase Genes in CREC: Prevalence, Mobility, and Resis

  2026-04-24

  Chen et al. (2025) provide a detailed molecular epidemiology of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong, China. The study reveals a high prevalence of blaNDM-1 on plasmids, frequent multidrug resistance, and extensive horizontal gene transfer, with important implications for infection control and Gram-negative bacterial infection research.

• Ademetionine in Neurological Disorders: Methylation and Clin

  2026-04-23

  This review synthesizes the neurochemical and clinical importance of methylation in neurological disorders, highlighting ademetionine (S-adenosylmethionine, SAMe) as a crucial methyl donor. The findings clarify how SAMe metabolism interfaces with folate and vitamin B12, impacting neuropsychiatric symptoms and offering therapeutic potential in depression, dementia, and remyelinating disorders.

• Maraviroc (UK-427857): Applied Workflows for HIV and Neuroin

  2026-04-23

  Maraviroc (UK-427857) enables precise HIV-1 entry inhibition and provides translational impact in neuroinflammation and ischemic stroke research. This article delivers actionable workflows, troubleshooting strategies, and protocol parameters—anchored in both literature and APExBIO’s product expertise—to optimize your research outcomes.

• mTORC1-IRE1α Axis Drives Palmitate-Induced Lipotoxicity in L

  2026-04-22

  This study reveals that activation of the mTORC1-IRE1α signaling pathway is central to palmitate-induced triglyceride overproduction and hepatocyte cell death. The mechanistic insight identifies potential therapeutic targets for metabolic diseases associated with lipotoxicity, such as nonalcoholic fatty liver disease.

14631 records 1/976 page Next 12345 下5页 Last page